Authors
Sen Mu, Hongyu Yang, Baihui Wei, Dongkai Wang, Ji Li
Published in
International journal of pharmaceutics. Pages 127680. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
Bone defects caused by trauma, tumor resection, infection, and degenerative diseases remain a major clinical challenge, especially critical-sized defects that surpass the inherent regenerative capacity of native bone tissue. Conventional bone grafting approaches, including autologous and allogeneic bone transplantation, are widely adopted in clinical practice. Nevertheless, their applications are limited by donor-site morbidity, immune rejection, and insufficient donor supply. Bioactive glasses (BGs), a family of inorganic biomaterials, can initiate cascaded regenerative responses through surface reactions and tunable ion release, covering osteogenesis, angiogenesis and immunomodulation. Therefore, BGs have become promising candidates for bone repair. To date, various BG-based forms have been fabricated, ranging from nanoparticles and porous scaffolds to injectable systems and surface-modified implant coatings. This review summarizes recent advances of BG biomaterials for bone defect repair, with particular focus on ion-mediated biological mechanisms, material modification strategies, and microenvironment regulation. Additionally, we discuss major bottlenecks hindering their clinical translation and propose prospects for future research.
PMID:
43033953
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0